SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001999371-24-000222
Filing Date
2024-01-08
Accepted
2024-01-08 16:33:41
Documents
5
Period of Report
2024-02-15

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tonix-def14a_021524.htm DEF 14A 160523
2 GRAPHIC proxy001.jpg GRAPHIC 1883
3 GRAPHIC proxy002.jpg GRAPHIC 9284
4 GRAPHIC proxy003.jpg GRAPHIC 5698
5 GRAPHIC proxy004.jpg GRAPHIC 10304
  Complete submission text file 0001999371-24-000222.txt   199644
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36019 | Film No.: 24520551
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)